JW Pharmaceutical Corp (001065) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.104x

Based on the latest financial reports, JW Pharmaceutical Corp (001065) has a cash flow conversion efficiency ratio of 0.104x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩42.51 Billion ≈ $28.81 Million USD) by net assets (₩409.94 Billion ≈ $277.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see JW Pharmaceutical Corp stock valuation for the company's overall valuation and market capitalisation.

JW Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how JW Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

JW Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JW Pharmaceutical Corp ranked by their cash flow conversion efficiency. Explore JW Pharmaceutical Corp earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Great Tree Pharmacy Co Ltd TWO:6469	0.120x
Perdana Karya Perkasa Tbk JK:PKPK	0.190x
Discount Investment Corp Ltd TA:DISI	0.018x
Zhejiang Dilong New Material Co Ltd SHE:002247	0.021x
Cantor Equity Partners II, Inc. NASDAQ:CEPT	N/A
Heilongjiang Interchina Water Treatment Co Ltd SHG:600187	0.005x
CLINUVEL PHARMAC.ADRS1 F:UR9A	N/A
RiverNorth Flexible Municipal Income Fund II Inc NYSE:RFMZ	N/A

Annual Cash Flow Conversion Efficiency for JW Pharmaceutical Corp (2014–2025)

The table below shows the annual cash flow conversion efficiency of JW Pharmaceutical Corp from 2014 to 2025. View JW Pharmaceutical Corp (001065) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩369.37 Billion ≈ $250.32 Million	₩96.40 Billion ≈ $65.33 Million	0.261x	+8.31%
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-155.99%
2014-12-31	₩220.02 Billion ≈ $149.11 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	--

About JW Pharmaceutical Corp

KO:001065 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$302.34 Million

₩446.13 Billion KRW

Market Cap Rank

#14883 Global

#476 in Korea

Share Price

₩22200.00

Change (1 day)

+1.83%

52-Week Range

₩19800.00 - ₩29850.00

All Time High

₩88605.96